ramer that "the aerospace industry has accelerated dramatically," he said. "Now, there are still some worries about China. I get that. But the demand flow is so strong that China may not even matter that much." That should benefit General Electric, Honeywell and Boeing, all of which specialize in segments of aerospace, Cramer said. Even so, he said United Technologies was his favorite "because of the disruptive new aircraft engine." Still, "the whole group is too low," he said. "That even includes GE, although the story there is a lot more messy thanks to the problems from long-term care insurance and the ailing power division. But Honeywell? Honeywell's just a buy."

2. 5G

5G, or the fifth generation of wireless mobile connectivity, "is starting to make an impact" as well, the "Mad Money" host said. "There's a reason why Xilinx reported the best quarter of any semiconductor company so far — they have the most to gain from the early adoption of 5G and they already have substantial orders," Cramer said adding that Xilinx "feels like the new Nvidia" because of its business lines in artificial intelligence, autonomous driving and, importantly, telecommunications. "[Xilinx] ignited a rally in the semiconductor cohort, aided by Lam Research, and I think the run is for real, even though Intel gave us some downbeat guidance after the close," he said.

3. Cancer

The third major theme is the world's largest biotechnology and pharmaceutical players racing to find the best ways to treat, or even cure, cancer, Cramer said. From Bristol-Myers Squibb's deal to buy Celgene to GlaxoSmithKline's purchase of Tesaro to Eli Lilly's acquisition of Loxo Oncology, most of the recent, high-profile deals in the health-care space center on the disease, he noted. "Put it all together and I think there are a ton of biotechs that might be worth speculating on here," Cramer said. "Anything with a credible cancer immunotherapy pipeline could be in play."

4. Digitization

The ongoing trend of companies moving their operations to digital formats, particularly the cloud, isn't stopping anytime soon, either, Cramer said. "That's the message we got from IBM, for instance, which is doing some very powerful work in health care," he said. "When you
ramer that " the aerospace industry has accelerated dramatically, " he said. " Now, there be however some worries about China. I get that. But the demand stream is so strong that China may not even count that much. " That should benefit General Electric, Honeywell and Boeing, all of which specialize in segments of aerospace, Cramer say. Even so, he said United Technologies was his favored " because of the disruptive new aircraft engine. " Still, " the whole group is excessively low, " he said. " That even includes GE, although the story there is a batch more messy thanks to the problems from long - term concern insurance and the ailing power division. But Honeywell? Honeywell's merely a buy. " 

 2. 5 G 

 5 G, or the fifth generation of wireless mobile connectivity, " is begin to make an impact " as well, the " Mad Money " host say. " There's a reason why Xilinx reported the best quarter of any semiconductor company so far — they have the most to gain from the early adoption of 5 gram and they already have substantial club, " Cramer suppose adding that Xilinx " feels like the new Nvidia " because of its clientele lines in artificial intelligence, autonomous driving and, importantly, telecommunications. " [ Xilinx ] inflame a rally in the semiconductor cohort, aided by Lam Research, and I think the run is for real, even though Intel give us some downbeat guidance after the close, " he said. 

 3. Cancer 

 The third major theme is the populace's largest biotechnology and pharmaceutical player racing to find the best ways to treat, or even cure, cancer, Cramer say. From Bristol - Myers Squibb's deal to buy Celgene to GlaxoSmithKline's purchase of Tesaro to Eli Lilly's learning of Loxo Oncology, most of the recent, high - profile deals in the health - concern space kernel on the disease, he noted. " Put it all in concert and I think there are a ton of biotechs that might be worth speculate on here, " Cramer said. " Anything with a credible cancer immunotherapy grapevine could be in play. " 

 4. Digitization 

 The ongoing trend of companies move their operations to digital format, particularly the cloud, isn't stopping anytime soon, either, Cramer said. " That's the message we got from IBM, for instance, which is doing some very powerful work in health caution, " he said. " When you
ramfr that "the aerospace inaustry has accelerated dramafically," fe said. "Now, there are still done woeries about China. I geg that. Bun the demqnd hlow is so stronj that Cmnna mzn not xven matter thaj much." That vhould benefit Gdnzral Electric, Honeywell and Boeing, ajl of wnifh specialize yn stgmqnts of aerospace, Cramer said. Even so, ge said United Technplogies was his favorite "bfcaude of the disruptige new airctzft wngine." Still, "the whole group is tok low," he said. "That even includer GE, clthough thg atlty there is e lot iore messy tmsnks tm the ptoblems from lpng-verm care insurance and tie ailing power divifion. But Voueywell? Honeywell's juwt a bui."

2. 5G

5G, mr tfw fkftg jensratioj oh wireless jobile connwctivity, "is startinb ei make an impzct" as wqll, the "Mad Money" host said. "There's a redsoh why Xilinx reported tye best quarter of ani semicondtctor company so far — they have the most to gain xrom vhd ecvjh afoption of 5G and they already have substantiaj otdvrs," Cramer said abding that Xilinc "verjs like the ngw Nvidnz" gecause of its buslness lynes un artifisial intelligence, autonomous druving and, imiortqntly, telecommunicctions. "[Xilinr] ignijed a tally in the semiconduccor cogort, aided hy Lam Readarch, and I thiny tme sun is for real, even thougr Intel geve ux some aownneat gtidance afher tma close," he said.

3. Cajcer

Tke thhrd major hheme is the world's largest biovxchnology and pvarkaceuticcl planers racing to sind the best cays to creat, ur even cuge, cancer, Cramer saiq. From Briston-Lyers Squibb'v deal tj but Ceogene tu GlaxoSmithKlime's purchcfe od Tesaro to Eli Likly'r acquisition of Lozo Oncology, mosy ow tre rxcent, vigh-profile gealr iv the fealth-care woace center on the diseave, hs noted. "Put it all tjgether qnd I thynk there are a ton of biotechs that mijht be wotth speculating on here," Cramer aaid. "Anytjinn with a credyble cancer immuuotherapy pipeline could be in play."

4. Digivization

The ongoing trgnd of companies moviug their operetions to digitdl formats, particulaely the cloud, isn'u stopping anytime soon, eithes, Craler said. "That's the message we got from IBM, for instance, which is doing sone verb [owerful wodk im heantk ccre," he faid. "Xhen you
ramer that "the aerospace industry has accelerated said. there are some worries about the flow is so that China may even matter that much." That should General Electric, Honeywell and Boeing, all of which specialize in segments of aerospace, said. Even so, he said United Technologies was his favorite "because of the new engine." "the group is too low," he said. "That even includes GE, although the story there is a more messy thanks to the problems from long-term insurance and the ailing division. But Honeywell? Honeywell's just buy." 5G 5G, the generation wireless mobile connectivity, starting to make an impact" as well, the "Mad Money" host said. "There's a reason why Xilinx the best any semiconductor so — have the most from the early adoption of 5G have substantial orders," Cramer said adding that Xilinx like the Nvidia" because of its business lines artificial intelligence, autonomous driving and, importantly, telecommunications. "[Xilinx] a rally in the semiconductor cohort, aided by Lam Research, and I think the run real, even though Intel us some downbeat after close," said. Cancer The major theme is the world's largest biotechnology and pharmaceutical players racing find the best ways to treat, or even cure, cancer, From Squibb's deal to Celgene to GlaxoSmithKline's purchase Tesaro Eli Lilly's acquisition of most the in health-care center on the disease, noted. "Put it all together I think there are might be worth speculating on here," Cramer said. with a credible cancer immunotherapy pipeline could in play." 4. Digitization The ongoing trend of companies moving their operations digital formats, cloud, isn't stopping anytime soon, either, Cramer said. the message we got IBM, for instance, which is doing some very powerful in care," he "When you
ramer that "the aerospace induStry has accEleraTed DraMaTicaLly," hE said. "Now, there aRE stiLl some worries about ChinA. I get ThAT. But THe DemanD flow is SO sTROng ThAt chiNa MAy Not evEn mAtter thAt much." That ShoUlD benefit GeneRAl electric, HoNeyWell and BoeinG, alL of whiCh SpeCIalizE in SegmeNts of aERospacE, Cramer saId. eVen so, hE Said UniTED TEchnOlogies was his favoRItE "Because of the diSruptiVe NEw AIRcrAft Engine." StilL, "tHe whoLE group iS ToO LOW," he SAid. "That even inCludes GE, altHOugH the stOrY thERe is a lOt morE mESsy Thanks to the ProbLems from lOng-terM Care insURance anD the aiLinG poWer dIViSiOn. BUt hOneYWeLl? HONeyWell's jusT a BuY."

2. 5G

5G, or The fIFTH GeneRatIon oF wireLess mobile conNecTiviTY, "is StartIng to Make An ImpacT" as welL, the "MAd money" host said. "ThEre's A reason whY XiLiNx rEpOrted THe best QuaRteR of any sEmicondUCtoR cOMPAnY so far — they have the mOsT TO gAin from tHe earlY AdOpTIon of 5G anD tHey AlreADY have SubsTAnTial ordeRs," CramER sAiD adding ThAt XiliNx "FeeLs lIke thE New NVidia" bEcause of Its buSIness lines in arTIficial intellIGeNCE, aUTonoMouS driving and, ImpoRTantLy, teLEcOmmUNicatIons. "[XIlINx] IGnited a rally in the seMiConducTor coHort, aided by LaM Research, aND i Think the Run iS FoR Real, even though intel Gave us some DOwnbeat gUidanCe after tHe close," he SAId.

3. Cancer

the ThiRd mAjoR THeMe is the world's LARgesT bIotechnOloGy and phArmAceUtiCal PlAyers raciNg to find ThE bEsT wAys To treAT, or even cUrE, caNcEr, CRamer SAid. FroM BrisTol-MYeRs sQuiBb's deal TO bUY celgEnE tO GlaXoSMiThKliNe's pURchAse of TeSaro to Eli lilLY's acQuIsItion of loxo Oncology, mOsT of the receNt, HigH-profiLE Deals in tHe health-care space center ON the disEasE, he noTed. "PUt it all toGetHer and i thINk therE are a tOn of bIoTecHS That mIGHt Be wOrTh speculatING on Here," CRaMer sAid. "AnytHing with a credible cANceR immunotherapY piPeliNE CoUld BE iN PlaY."

4. DIGitIZAtion

The ongoing Trend of comPaNIeS moving theIR opErAtions tO digitaL formATs, partiCularly thE cloud, isn'T sToppING anYtime soon, eIther, CraMer said. "ThAT's the MEsSage wE goT from IbM, For InstaNce, whiCH is Doing Some veRy PowerfUl worK iN health cAre," he said. "When you
ramer that "the aerospaceindustry h as ac cel era te d dr amat ically," he sa i d. " Now, there are still s ome w or r iesa bo ut Ch ina. Ig et t hat .Bu t t he de mandflo w is so  strong th atCh ina may note ve n matter t hat  much." That  sh ould b en efi t  Gene ral  Elec tric,H oneywe ll and Bo ei n g, all of whic h sp ecia lize in segmentso fa erospace, Cram er sai d. Ev e n  so , h e said Uni te d Tec h nologie s  w a s his favorite "bec ause of the dis ruptiv enew aircra ft en gi n e."  Still, "th e wh ole group  is to o  low,"h e said.  "That  ev enincl u de sGE,  a l tho u gh  th e  st ory ther eis  a lo t mo r e m essy  th anks  to t he problems f rom  lon g -te rm ca re in sura nc e and  the a iling  p ower division.ButHoneywell ? H on eyw el l's j u st a b uy. "
2. 5G
5G, ort hefi f t h  g eneration of wirel es s mo bile con nectiv i ty ," is start in g t o ma k e  an i mpac t "as well,  the " M ad  M oney" h os t said ."Th ere 's ar easo n whyXilinx r eport e d the best qua r ter of any se m ic o n du c torcom pany so far  — t h ey h avet he  mo s t togainfr o mt he early adoption o f5G and  they  already have  substanti a l orders,"  Cra m er said adding th at Xi linx "feel s  like th e new  Nvidia"  becauseo f  its bus ine sslin esi n  a rtificial int e l lige nc e, auto nom ous dri vin g a nd,  im po rtantly,telecomm un ic at io ns.  "[Xi l inx] ign it edaral ly in the se micon duct or  c o hor t, aide d  b y LamRe se arch , a nd  I th inkt herun isfor real,  ev e n th ou gh  Intelgave us somedo wnbeat gui da nce  after t he close ," he said.

3. CancerThe thi rdmajor  the me is the  wo rld'slar g est bi otechn ology  a ndp h armac e u ti cal  p layers rac i n g t o fin dthebest wa ys to treat, or ev e n c ure, cancer,Cra mers a id . F r om Bri st o l-M y e rs Squibb's dea l to buy C el g en e to Glaxo S mit hK line'spurchas e ofT esaro t o Eli Lil ly's acqu is itio n ofLoxo Oncol ogy, mos t of ther ecent ,  h igh-p rof ile de al s i n the  healt h -ca re sp ace ce nt er onthe d is ease, he  noted. "Put it all tog etherand I  th ink there  ar e  aton of bi otec hs that mi ght  be  wort h s p ecula ting on  he r e," C rame r  said. "A n yt hin g wi th a credib l e can cer i mmu n othera py p ipeline could bei n play."

4. D igit i z ati onTheon going trend of  co mp a n ies movi ng  their oper ations t od igita l form ats, p articul a r ly the cl oud,  is n't stopp ing  a n ytime s oo n, either , Cr am er sai d. "Th a t'st h e message we got  from I BM, f o r i nstan ce , which is d oing somevery powerf ul wor k in  heal th care ,"  he sa id.  " When you
ramer that_"the aerospace_industry has accelerated dramatically,"_he said._"Now,_there are_still_some worries about_China. I get_that. But the demand_flow is so_strong_that China may not even matter that much." That should benefit General Electric, Honeywell_and_Boeing, all_of_which_specialize in segments of aerospace,_Cramer said. Even so, he_said United_Technologies was his favorite "because of the disruptive_new_aircraft engine." Still,_"the whole group is too low," he said. "That_even includes GE, although the story_there is a_lot_more_messy thanks to the_problems from long-term care insurance and_the ailing power division. But Honeywell?_Honeywell's just a buy."

2. 5G

5G, or the_fifth generation of wireless mobile connectivity,_"is starting to make an_impact" as_well, the "Mad Money" host_said. "There's a_reason why_Xilinx reported the_best quarter of any semiconductor company_so far —_they have the most to gain_from_the early adoption_of_5G_and they_already have substantial_orders,"_Cramer said_adding_that Xilinx "feels like the new_Nvidia"_because of its business lines in artificial_intelligence, autonomous driving and,_importantly,_telecommunications. "[Xilinx] ignited a_rally in the semiconductor cohort,_aided by Lam Research, and I_think the_run is_for real, even though Intel gave us some downbeat guidance after_the close," he said.

3. Cancer

The third_major theme is the_world's largest_biotechnology_and pharmaceutical players_racing_to find_the best ways to treat, or even_cure, cancer,_Cramer said. From Bristol-Myers Squibb's deal_to buy Celgene to_GlaxoSmithKline's_purchase of Tesaro to Eli Lilly's_acquisition of Loxo Oncology, most of_the recent, high-profile deals in_the_health-care_space center on the disease,_he noted. "Put it all together_and I think_there are a ton of biotechs that_might_be worth speculating on here," Cramer_said._"Anything with a credible cancer immunotherapy_pipeline_could_be in play."

4. Digitization

The ongoing_trend of companies moving their operations_to digital formats, particularly the cloud, isn't stopping anytime_soon, either, Cramer_said. "That's the message we_got_from_IBM, for instance, which is doing some very powerful work_in health_care," he said._"When you